No abstract available
Keywords:
Denosumab; Dénosumab; Hypocalcemia; Hypocalcémie; Maladie osseuse de Paget; Paget's disease of bone.
MeSH terms
-
Aged
-
Bone Density Conservation Agents / adverse effects*
-
Denosumab / adverse effects*
-
Glomerular Filtration Rate
-
Humans
-
Hypocalcemia / chemically induced*
-
Male
-
Osteitis Deformans / diagnosis*
-
Renal Insufficiency / diagnosis*
Substances
-
Bone Density Conservation Agents
-
Denosumab